Search
Outlook Therapeutics Inc
OTLKAdd to Watchlist
0.641USD
-0.025-3.75%
Close 09-08 16:00（ET）
119.93MMarket Cap
LossP/E TTM
Outlook Therapeutics Inc's Company Valuation
Currency: USD Updated: 2026-09-04The current valuation score of Outlook Therapeutics Inc is 9.47, ranking 28 out of 368 in the Biotechnology & Medical Research industry. Its current P/E ratio is -0.59, which is -184.27% below the recent high of 0.50 and -1191.02% above the recent low of -7.62.
P/E
Relevant data have not been disclosed by the company yet.
P/B
Relevant data have not been disclosed by the company yet.
P/S
Relevant data have not been disclosed by the company yet.
P/CF
Relevant data have not been disclosed by the company yet.